(2S)-Naringenin from Typha angustata inhibits vascular smooth muscle cell proliferation via a G0/G1 arrest

被引:26
作者
Lee, Jung-Jin [2 ]
Yi, Hyoseok
Kim, In-Su
Kim, Yohan
Nguyen Xuan Nhiem [3 ]
Kim, Young Ho [3 ]
Myung, Chang-Seon [1 ,2 ]
机构
[1] Chungnam Natl Univ, Coll Pharm, Dept Pharmacol, Inst Drug Res & Dev, Taejon 305764, South Korea
[2] Korea Inst Oriental Med, TKM Based Herbal Drug Res Grp, Dajeon 305811, South Korea
[3] Chungnam Natl Univ, Coll Pharm, Dept Nat Prod Chem, Taejon 305764, South Korea
关键词
(2S)-Naringenin; Typha angustata; Antiproliferative activity; Vascular smooth muscle cell; Cell cycle; ATHEROSCLEROSIS; PHOSPHORYLATION; PROGRESSION; NARINGENIN; HYPERPLASIA; EXPRESSION; DISEASE; GROWTH; CYCLE;
D O I
10.1016/j.jep.2011.12.038
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Typha angustata is used in traditional Chinese medicine for a variety of clinical disorders. Its pharmacological actions include beneficial effects on hyperlipidemia and myocardial infarction, as well as labor-inducing and antibacterial effects. Aim of the study: We investigated the mechanism underlying the ability of (2S)-naringenin, an active compound from Typha angustata, to inhibit the proliferation of vascular smooth muscle cells (VSMCs). Materials and methods: After measuring the antiproliferative effect of (2S)-naringenin on VSMC proliferation using cell proliferation and viability assays, the possible involvement of a signaling pathway associated with platelet-derived growth factor receptor beta (PDGF-R beta), extracellular signal regulated kinase 1/2 (ERK1/2), phosphatidylinositol 3-kinase (PI3K)-linked protein kinase B (Akt/PKB), or phospholipase C-gamma 1 (PLC gamma 1) was investigated by immunoblotting. Moreover, the effect of (2S)-naringenin on DNA synthesis and the cell cycle was examined using a [H-3]-thymidine incorporation assay and flow cytometry. Results: (2S)-Naringenin significantly inhibited PDGF-BB-induced VSMC proliferation in a concentration-dependent manner, but did not affect signaling pathways associated with PDGF-R beta, Akt/PKB, ERK1/2, or PLC-gamma 1. However, (2S)-naringenin suppressed DNA synthesis via a G(0)/G(1) cell cycle arrest. Accordingly, the expression of cyclins D1 and E and cyclin-dependent kinases 2 and 4 was inhibited in a concentration-dependent manner; moreover, the phosphorylation of retinoblastoma protein was suppressed. Conclusions: Our results show that (2S)-naringenin inhibited the PDGF-BB-induced proliferation of VSMCs via a G(0)/G(1) arrest; thus, (2S)-naringenin may be valuable as a therapeutic agent for managing atherosclerosis and/or vascular restenosis. Crown Copyright (C) 2011 Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:873 / 878
页数:6
相关论文
共 36 条
  • [1] PHOSPHORYLATION OF THE RETINOBLASTOMA PROTEIN BY CDK2
    AKIYAMA, T
    OHUCHI, T
    SUMIDA, S
    MATSUMOTO, K
    TOYOSHIMA, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (17) : 7900 - 7904
  • [2] Cell cycle-dependent regulation of smooth muscle cell activation
    Braun-Dullaeus, RC
    Mann, MJ
    Sedding, DG
    Sherwood, SW
    von der Leyen, HE
    Dzau, VJ
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : 845 - 850
  • [3] Naringenin Inhibits Neointimal Hyperplasia Following Arterial Reconstruction With Interpositional Vein Graft
    Cayci, Cenk
    Wahlquist, Trevor C.
    Seckin, Serin I.
    Ozcan, Vefa
    Tekinay, Ayse B.
    Martens, Timothy P.
    Oz, Mehmet C.
    Ascherman, Jeffrey A.
    [J]. ANNALS OF PLASTIC SURGERY, 2010, 64 (01) : 105 - 113
  • [4] CHAMLEY JH, 1977, CELL TISSUE RES, V177, P503
  • [5] Bacterial pretreatment enhances removal of heavy metals during treatment of post-methanated distillery effluent by Typha angustata L.
    Chandra, R.
    Yadav, S.
    Bharagava, R. N.
    Murthy, R. C.
    [J]. JOURNAL OF ENVIRONMENTAL MANAGEMENT, 2008, 88 (04) : 1016 - 1024
  • [6] G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts
    Connell-Crowley, L
    Elledge, SJ
    Harper, JW
    [J]. CURRENT BIOLOGY, 1998, 8 (01) : 65 - 68
  • [7] Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies
    Dzau, VJ
    Braun-Dullaeus, RC
    Sedding, DG
    [J]. NATURE MEDICINE, 2002, 8 (11) : 1249 - 1256
  • [8] Atherosclerotic vascular disease conference - Writing group III: Pathophysiology
    Faxon, DP
    Fuster, V
    Libby, P
    Beckman, JA
    Hiatt, WR
    Thompson, RW
    Topper, JN
    Annex, BH
    Rundback, JH
    Fabunmi, RP
    Robertson, RM
    Loscalzo, J
    [J]. CIRCULATION, 2004, 109 (21) : 2617 - 2625
  • [9] PHARMACOLOGICAL PREVENTION OF RESTENOSIS AFTER CORONARY ANGIOPLASTY - REVIEW OF THE RANDOMIZED CLINICAL-TRIALS
    FRANKLIN, SM
    FAXON, DP
    [J]. CORONARY ARTERY DISEASE, 1993, 4 (03) : 232 - 242
  • [10] Frydoonfar H R, 2003, Colorectal Dis, V5, P149, DOI 10.1046/j.1463-1318.2003.00444.x